Emicizumab (Hemlibra)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Emicizumab (Hemlibra), covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis [Phase 4]